Log Out | Member Center

65°F

86°/65°

Wisconsin receives $200,000 in drug settlement

  • The Associated Press
  • Published Wednesday, July 16, 2014, at 10:58 a.m.
  • Updated Wednesday, July 16, 2014, at 10:58 a.m.

— Wisconsin will receive $200,000 for its Medicaid program from the settlement of a multi-state lawsuit accusing a pharmaceutical company of improperly marketing a drug.

Wisconsin State Journal reported Wednesday (http://bit.ly/1qHae49 ) that Illinois-based Astellas Pharma US Inc. will pay a total of $7.3 million in the settlement with multiple states and the federal government.

The Wisconsin Attorney General's Office says in a statement that the company promoted pediatric use of the drug Mycamine from 2005 to 2010, even though the Food and Drug Administration hadn't approved it for children.

The anti-fungal agent is approved for use in adults with certain infections. It also can be used to prevent infections in adults undergoing stem cell transplants.

Information from: Wisconsin State Journal, http://www.madison.com/wsj

Subscribe to our newsletters

The Wichita Eagle welcomes your comments on news of the day. The more voices engaged in conversation, the better for us all, but do keep it civil. Please refrain from profanity, obscenity, spam, name-calling or attacking others for their views. Please see our commenting policy for more information.

Have a news tip? You can send it to wenews@wichitaeagle.com.

Search for a job

in

Top jobs